ID

15075

Descrizione

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470; ODM derived from: https://clinicaltrials.gov/show/NCT02302443

collegamento

https://clinicaltrials.gov/show/NCT02302443

Keywords

versioni (1)
  1. 14/05/16 14/05/16 -
Caricato su

14 maggio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetes Mellitus NCT02302443

Inglese

Eligibility Diabetes Mellitus NCT02302443

1 moduli  
Criteria
Descrizione

Criteria

t2dm more than 12 monthm
Descrizione

Diabetes Mellitus, Non-Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011860
age ≥18 and ≤70 years
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
body mass index between 18.0 and 35.0 kg/m2 inclusive.
Descrizione

Body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1305855
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
Descrizione

Healthy | Medical History | Physical Examination | Biochemical finding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3898900
UMLS CUI [2]
C0262926
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0428132
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
Descrizione

Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0086287
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0041275
UMLS CUI [6]
C0020699
UMLS CUI [7]
C2243030
UMLS CUI [8]
C0278321
UMLS CUI [9]
C0232970
UMLS CUI [10]
C0086582
UMLS CUI [11]
C0024559
UMLS CUI [12]
C0036899
UMLS CUI [13]
C3831118
UMLS CUI [14]
C0700589
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
Descrizione

Informed Consent | Research Activities

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0242481
inclusion criteria for t2dm:
Descrizione

Inclusion | Diabetes Mellitus, Non-Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1512693
UMLS CUI [2]
C0011860
t1dm more than 12 monthm
Descrizione

Diabetes Mellitus, Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
age ≥18 and ≤70 years
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
body mass index between 18.0 and 30.0 kg/m2 inclusive.
Descrizione

Body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1305855
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
Descrizione

Healthy | Medical History | Physical Examination | Biochemical finding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3898900
UMLS CUI [2]
C0262926
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0428132
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
Descrizione

Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0086287
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0041275
UMLS CUI [6]
C0020699
UMLS CUI [7]
C2243030
UMLS CUI [8]
C0278321
UMLS CUI [9]
C0232970
UMLS CUI [10]
C0086582
UMLS CUI [11]
C0024559
UMLS CUI [12]
C0036899
UMLS CUI [13]
C3831118
UMLS CUI [14]
C0700589
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
Descrizione

informed consent | Research Activities

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0242481
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
a subject who has proliferative retinopathy or maculopathy, severe gastroparesis, and/or severe neuropathy, in particular autonomic neuropathy, as judged by the investigator
Descrizione

Proliferative retinopathy | Disorder of macula of retina Proliferative | Gastroparesis Severe | Neuropathy Severe | Autonomic neuropathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0339467
UMLS CUI [2,1]
C0730362
UMLS CUI [2,2]
C0334094
UMLS CUI [3,1]
C0152020
UMLS CUI [3,2]
C0205082
UMLS CUI [4,1]
C0442874
UMLS CUI [4,2]
C0205082
UMLS CUI [5]
C0259749
recurrent major hypoglycemia or hypoglycemic unawareness or recent ketoacidosis
Descrizione

Hypoglycemia Major Recurrent | Hypoglycemia unawareness | Ketoacidosis Recent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205164
UMLS CUI [1,3]
C2945760
UMLS CUI [2]
C0342317
UMLS CUI [3,1]
C0220982
UMLS CUI [3,2]
C0332185
pregnant or lactating women
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
participation in an investigational study within 30 days prior to dosing
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
clinically significant abnormal ecg at screening, as judged by the investigator
Descrizione

Electrocardiogram abnormal

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0522055
Ritorna all'inizio della pagina

Similar models

Eligibility Diabetes Mellitus NCT02302443

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Diabetes Mellitus, Non-Insulin-Dependent
Item
t2dm more than 12 monthm
boolean
C0011860 (UMLS CUI [1])
Age
Item
age ≥18 and ≤70 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index between 18.0 and 35.0 kg/m2 inclusive.
boolean
C1305855 (UMLS CUI [1])
Healthy | Medical History | Physical Examination | Biochemical finding
Item
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
boolean
C3898900 (UMLS CUI [1])
C0262926 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
C0428132 (UMLS CUI [4])
Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods
Item
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
boolean
C0086287 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0041275 (UMLS CUI [5])
C0020699 (UMLS CUI [6])
C2243030 (UMLS CUI [7])
C0278321 (UMLS CUI [8])
C0232970 (UMLS CUI [9])
C0086582 (UMLS CUI [10])
C0024559 (UMLS CUI [11])
C0036899 (UMLS CUI [12])
C3831118 (UMLS CUI [13])
C0700589 (UMLS CUI [14])
Informed Consent | Research Activities
Item
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
boolean
C0021430 (UMLS CUI [1])
C0242481 (UMLS CUI [2])
Inclusion | Diabetes Mellitus, Non-Insulin-Dependent
Item
inclusion criteria for t2dm:
boolean
C1512693 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent
Item
t1dm more than 12 monthm
boolean
C0011854 (UMLS CUI [1])
Age
Item
age ≥18 and ≤70 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
body mass index between 18.0 and 30.0 kg/m2 inclusive.
boolean
C1305855 (UMLS CUI [1])
Healthy | Medical History | Physical Examination | Biochemical finding
Item
considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the investigator.
boolean
C3898900 (UMLS CUI [1])
C0262926 (UMLS CUI [2])
C0031809 (UMLS CUI [3])
C0428132 (UMLS CUI [4])
Females | Pregnancy | Breast Feeding | Female Sterilization | Tubal Occlusion | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy | Postmenopausal state | Males | Male sterilization | Sexual Abstinence | Childbearing Potential | Contraceptive methods
Item
females must be non-pregnant and non-lactating, and either surgically sterile (e.g., tubal occlusion, hysterectomy, bilateral salpingectomy, bilateral oophorectomy) or post-menopausal for >12 months. males must be surgically sterile, abstinent or if engaged in sexual relations of child-bearing potential, the subject must be using an acceptable contraceptive method during and for during a period of 60 days after the last dose of study drug.
boolean
C0086287 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
C0041275 (UMLS CUI [5])
C0020699 (UMLS CUI [6])
C2243030 (UMLS CUI [7])
C0278321 (UMLS CUI [8])
C0232970 (UMLS CUI [9])
C0086582 (UMLS CUI [10])
C0024559 (UMLS CUI [11])
C0036899 (UMLS CUI [12])
C3831118 (UMLS CUI [13])
C0700589 (UMLS CUI [14])
informed consent | Research Activities
Item
signed and dated informed consent obtained before any trial-related activities. (trial-related activities are any procedure that would not have been performed during normal management of the subject).
boolean
C0021430 (UMLS CUI [1])
C0242481 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Proliferative retinopathy | Disorder of macula of retina Proliferative | Gastroparesis Severe | Neuropathy Severe | Autonomic neuropathy
Item
a subject who has proliferative retinopathy or maculopathy, severe gastroparesis, and/or severe neuropathy, in particular autonomic neuropathy, as judged by the investigator
boolean
C0339467 (UMLS CUI [1])
C0730362 (UMLS CUI [2,1])
C0334094 (UMLS CUI [2,2])
C0152020 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0442874 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0259749 (UMLS CUI [5])
Hypoglycemia Major Recurrent | Hypoglycemia unawareness | Ketoacidosis Recent
Item
recurrent major hypoglycemia or hypoglycemic unawareness or recent ketoacidosis
boolean
C0020615 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C2945760 (UMLS CUI [1,3])
C0342317 (UMLS CUI [2])
C0220982 (UMLS CUI [3,1])
C0332185 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in an investigational study within 30 days prior to dosing
boolean
C2348568 (UMLS CUI [1])
Electrocardiogram abnormal
Item
clinically significant abnormal ecg at screening, as judged by the investigator
boolean
C0522055 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial